A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study, in ...

A partnership between AI specialist Owkin and drugmaker AstraZeneca has been formed to find tools that can be applied to ...

In the SAPPHIRE trial, Scholar Rock tested apitegromab in patients aged two to 12 who were already being treated with the ...

Victor Ambros and Gary Ruvkun have shared this year's Nobel Prize in Physiology or Medicine for their discovery of microRNA, ...

To establish a good basis, the mentor needs to ask relevant questions. Looking at a situation from diverse angles is ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

Characterised by the abnormal accumulation of two proteins, amyloid beta and phosphorylated tau (pTau), AD progresses ...

The figures show that ADHD medicine prescriptions have seen the steepest rise, particularly since 2020/21. Last year, 278,000 ...

AZ said adding YS2302018 to its pipeline strengthens its cardiovascular portfolio with a drug that could have potential in a ...

UK Health Secretary Wes Streeting has announced plans to allow NHS England to share primary care data with scientific ...

The phase 3b BATURA study showed Airsupra (albuterol/budesonide) achieved a statistically significant reduction in the risk of severe asthma exacerbations when used as needed for rescue therapy ...

The week has started with reports that activist investor Starboard Value has amassed a $1 billion stake in pharma group ...